Relu has announced both a 510(k) clearance by the US Food and Drug Administration (FDA) and CE Mark approval by an EU-notified body. These regulatory milestones authorise the commercial distribution of the Relu Creator, a dental tool that enables users to create 3D anatomical models from patients in just minutes.
FDA clearance signifies compliance with US medical device standards, while the CE Mark confirms adherence to EU regulations for product safety and consumer protection.
“We are thrilled to have attained both FDA and CE approval for the Relu Creator,” stated Adriaan Van Gerven, CTO and co-founder of Relu. “These significant achievements are a testament to Relu’s dedication to creating superior technology that meets the highest international safety and quality standards. We’re poised to revolutionize patient and dentist experiences across both continents.”
“This approval paves the way for our advanced technology to enter US and EU dental markets with the highest potential for growth. Having led strategy in dental, AI and orthodontic sectors, I consider this achievement a key differentiator that sets Relu Creator apart. This is a major step forward in Relu’s mission to modernise dental care,” said Bindu Saran, and board member of Relu.
The Relu Creator integrates AI to deliver features such as automated anatomical identification, and enhanced 3D imaging for dental diagnostics and treatment planning. By improving precision and increasing overall efficiency in dental procedures, Relu Creator supports efficient practices at modern dental clinics.
